Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy

NCT04138628 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Bladder Cancer, Metastatic

Interventions

DRUG: Atezolizumab

Sponsor

Jørgen Bjerggaard Jensen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]